/GE%20HealthCare%20Technologies%20Inc%20logo%20on%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Based in Chicago, Illinois, GE HealthCare Technologies Inc. (GEHC) engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. With a market cap of $28.7 billion, the company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The company is expected to report its Q1 earnings on Tuesday, Apr. 29. Ahead of the event, analysts expect GEHC to report an EPS of $0.91 per share, up 1.1% from $0.90 per share reported in the year-ago quarter. It has exceeded or met analysts' earnings estimates in all of the past four quarters, which is notable. Its adjusted EPS of $1.45 in the recent quarter surpassed analysts’ expectations by 15.1%, driven by demand in its Advanced Visualization Solutions and Pharmaceutical Diagnostics businesses.
